Using tree-based scan statistics to assess vaccines for possible associations with Guillain-Barré syndrome in the Vaccine Safety Datalink. [PDF]
Yih WK +14 more
europepmc +1 more source
The impact of the investigational human immunodeficiency virus type 1 (HIV-1) F4/AS01(B) vaccine on HIV-1 viral load (VL) was evaluated in antiretroviral therapy (ART)-naive HIV-1 infected adults.This phase IIb, observer-blind study (NCT01218113 ...
Bouchaud, Olivier +35 more
core
Assessing the impact of routine malaria vaccination on total disease burden in Cameroon: a nationwide difference‑in‑differences analysis using health district surveillance data (2023-2025). [PDF]
Bekolo CE +3 more
europepmc +1 more source
Respiratory Syncytial Virus Vaccine Effectiveness Among US Older Adults, 2023-2024 Season.
Lu Y +15 more
europepmc +1 more source
A phase III, double-blind, randomized, controlled trial (NCT00866619) in sub-Saharan Africa showed RTS,S/AS01 vaccine efficacy against malaria. We now present in-depth safety results from this study.
Masoud, Nahya Salim +40 more
core
Comparative Cytokine and Histology Studies on HPV and Other Viral Vaccinations: No Pathogenicity of HPV Vaccine Adjuvants. [PDF]
Shiro R +9 more
europepmc +1 more source
Need for Real-World Evaluation of Malaria Vaccines and Reliable Vaccination Records in Africa. [PDF]
Ko YK +6 more
europepmc +1 more source
Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methods. [PDF]
Schellenberg D +9 more
europepmc +1 more source
Vaccine Adjuvants and Delivery Systems: A Comprehensive Review. [PDF]
García AH, De Sanctis JB.
europepmc +1 more source
Advances in population-based interventions to control falciparum malaria. [PDF]
Glossop SE, Peto TJ, Adhikari B.
europepmc +1 more source

